MiT/TFE Family of Transcription Factors, Lysosomes, and Cancer

Literature Cited

1. Amin MB, Amin MB, Tamboli P, Javidan J, Stricker H et al. 2002. Prognostic impact of histologic subtyping of adult renal epithelial neoplasms: an experience of 405 cases. Am. J. Surg. Pathol. 26:3281–91
   [Google Scholar]
2. Andrews NW, de Almeida PE, Corrotte M 2014. Damage control: cellular mechanisms of plasma membrane repair. Trends Cell Biol 24:12734–42
   [Google Scholar]
3. Argani P, Antonescu CR, Illei PB, Lui MY, Timmons CF et al. 2001. Primary renal neoplasms with the ASPL-TFE3 gene fusion of alveolar soft part sarcoma. Am. J. Pathol. 159:1179–92
   [Google Scholar]
4. Argani P, Hicks J, De Marzo AM, Albadine R, Illei PB et al. 2010. Xp11 translocation renal cell carcinoma (RCC): extended immunohistochemical profile emphasizing novel RCC markers. Am. J. Surg. Pathol. 34:91295–303
   [Google Scholar]
5. Argani P, Lal P, Hutchinson B, Lui MY, Reuter VE, Ladanyi M 2003.a Aberrant nuclear immunoreactivity for TFE3 in neoplasms with TFE3 gene fusions: a sensitive and specific immunohistochemical assay. Am. J. Surg. Pathol. 27:6750–61
   [Google Scholar]
6. Argani P, Lui MY, Couturier J, Bouvier R, Fournet J-C, Ladanyi M 2003.b A novel CLTC-TFE3 gene fusion in pediatric renal adenocarcinoma with t(X;17)(p11.2;q23). Oncogene 22:345374–78
   [Google Scholar]
7. Azizi AA, Haberler C, Czech T, Gupper A, Prayer D et al. 2006. Vascular-endothelial-growth-factor (VEGF) expression and possible response to angiogenesis inhibitor bevacizumab in metastatic alveolar soft part sarcoma. Lancet Oncol 7:6521–23
   [Google Scholar]
8. Beckmann H, Su LK, Kadesch T 1990. TFE3: a helix-loop-helix protein that activates transcription through the immunoglobulin enhancer μE3 motif. Genes Dev 4:2167–79
   [Google Scholar]
9. Bertolotto C, Lesueur F, Giuliano S, Strub T, de Lichy M et al. 2011. A SUMOylation-defective MITF germline mutation predisposes to melanoma and renal carcinoma. Nature 480:737594–98
   [Google Scholar]
10. Bodine SC, Latres E, Baumhueter S, Lai VK, Nunez L et al. 2001. Identification of ubiquitin ligases required for skeletal muscle atrophy. Science 294:55471704–8
    [Google Scholar]
11. Boone BA, Bahary N, Zureikat AH, Moser AJ, Normolle DP et al. 2015. Safety and biologic response of pre-operative autophagy inhibition in combination with gemcitabine in patients with pancreatic adenocarcinoma. Ann. Surg. Oncol. 22:134402–10
    [Google Scholar]
12. Bruder E, Passera O, Harms D, Leuschner I, Ladanyi M et al. 2004. Morphologic and molecular characterization of renal cell carcinoma in children and young adults. Am. J. Surg. Pathol. 28:91117–32
    [Google Scholar]
13. Buerger C, DeVries B, Stambolic V 2006. Localization of Rheb to the endomembrane is critical for its signaling function. Biochem. Biophys. Res. Commun. 344:3869–80
    [Google Scholar]
14. Buscà R, Berra E, Gaggioli C, Khaled M, Bille K et al. 2005. Hypoxia-inducible factor 1α is a new target of microphthalmia-associated transcription factor (MITF) in melanoma cells. J. Cell Biol. 170:149–49
    [Google Scholar]
15. Cadwell K, Debnath J 2018. Beyond self-eating: the control of nonautophagic functions and signaling pathways by autophagy-related proteins. J. Cell Biol. 217:3813–22
    [Google Scholar]
16. Calcagnì A, Kors L, Verschuren E, De Cegli R, Zampelli N et al. 2016. Modelling TFE renal cell carcinoma in mice reveals a critical role of WNT signaling. eLife 5:e17047
    [Google Scholar]
17. Cancer Genome Atlas Res. Netw. 2013. Comprehensive molecular characterization of clear cell renal cell carcinoma. Nature 499:745643–49
    [Google Scholar]
18. Cancer Genome Atlas Res. Netw. 2015. Genomic classification of cutaneous melanoma. Cell 161:71681–1681
    [Google Scholar]
19. Cancer Genome Atlas Res. Netw. 2016. Comprehensive molecular characterization of papillary renal-cell carcinoma. N. Engl. J. Med. 374:2135–45
    [Google Scholar]
20. Cheng X, Zhang X, Gao Q, Ali Samie M, Azar M et al. 2014. The intracellular Ca²⁺ channel MCOLN1 is required for sarcolemma repair to prevent muscular dystrophy. Nat. Med. 20:101187–92
    [Google Scholar]
21. Cheng X, Zhang X, Yu L, Xu H 2015. Calcium signaling in membrane repair. Semin. Cell Dev. Biol. 45:24–31
    [Google Scholar]
22. Clark J, Lu YJ, Sidhar SK, Parker C, Gill S et al. 1997. Fusion of splicing factor genes PSF and NonO (p54^nrb) to the TFE3 gene in papillary renal cell carcinoma. Oncogene 15:182233–39
    [Google Scholar]
23. Commisso C, Davidson SM, Soydaner-Azeloglu RG, Parker SJ, Kamphorst JJ et al. 2013. Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature 497:7451633–37
    [Google Scholar]
24. Conner SD, Schmid SL 2003. Regulated portals of entry into the cell. Nature 422:692737–44
    [Google Scholar]
25. Cronin JC, Wunderlich J, Loftus SK, Prickett TD, Wei X et al. 2009. Frequent mutations in the MITF pathway in melanoma. Pigment Cell Melanoma Res 22:4435–44
    [Google Scholar]
26. Davidson SM, Jonas O, Keibler MA, Hou HW, Luengo A et al. 2017. Direct evidence for cancer-cell-autonomous extracellular protein catabolism in pancreatic tumors. Nat. Med. 23:2235–41
    [Google Scholar]
27. Davidson SM, Papagiannakopoulos T, Olenchock BA, Heyman JE, Keibler MA et al. 2016. Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer. Cell Metab 23:3517–28
    [Google Scholar]
28. Davies H, Bignell GR, Cox C, Stephens P, Edkins S et al. 2002. Mutations of the BRAF gene in human cancer. Nature 417:6892949–54
    [Google Scholar]
29. Davis IJ, Hsi B-L, Arroyo JD, Vargas SO, Yeh YA et al. 2003. Cloning of an Alpha-TFEB fusion in renal tumors harboring the t(6;11)(p21;q13) chromosome translocation. PNAS 100:106051–56
    [Google Scholar]
30. de Duve C. 2005. The lysosome turns fifty. Nat. Cell Biol. 7:9847–49
    [Google Scholar]
31. De Palma M, Biziato D, Petrova TV 2017. Microenvironmental regulation of tumour angiogenesis. Nat. Rev. Cancer 17:8457–74
    [Google Scholar]
32. DeNicola GM, Cantley LC 2015. Cancer's fuel choice: new flavors for a picky eater. Mol. Cell. 60:4514–23
    [Google Scholar]
33. Di Fiore PP, von Zastrow M 2014. Endocytosis, signaling, and beyond. Cold Spring Harb. Perspect. Biol. 6:8a016865
    [Google Scholar]
34. Di Malta C, Siciliano D, Calcagni A, Monfregola J, Punzi S et al. 2017. Transcriptional activation of RagD GTPase controls mTORC1 and promotes cancer growth. Science 356:63431188–92
    [Google Scholar]
35. Eddy RJ, Weidmann MD, Sharma VP, Condeelis JS 2017. Tumor cell invadopodia: invasive protrusions that orchestrate metastasis. Trends Cell Biol 27:8595–607
    [Google Scholar]
36. Ennen M, Keime C, Kobi D, Mengus G, Lipsker D et al. 2015. Single-cell gene expression signatures reveal melanoma cell heterogeneity. Oncogene 34:253251–63
    [Google Scholar]
37. Fan Y, Lu H, Liang W, Garcia-Barrio MT, Guo Y et al. 2018. Endothelial TFEB (transcription factor EB) positively regulates postischemic angiogenesis. Circ. Res. 122:7945–57
    [Google Scholar]
38. Farley MN, Schmidt LS, Mester JL, Pena-Llopis S, Pavia-Jimenez A et al. 2013. A novel germline mutation in BAP1 predisposes to familial clear-cell renal cell carcinoma. Mol. Cancer Res. 11:91061–71
    [Google Scholar]
39. Ferron M, Settembre C, Shimazu J, Lacombe J, Kato S et al. 2013. A RANKL-PKCβ-TFEB signaling cascade is necessary for lysosomal biogenesis in osteoclasts. Genes Dev 27:8955–69
    [Google Scholar]
40. Ghose A, Tariq Z, Veltri S 2012. Treatment of multidrug resistant advanced alveolar soft part sarcoma with sunitinib. Am. J. Ther. 19:1e56–58
    [Google Scholar]
41. Goldstein JL, Brown MS 2015. A century of cholesterol and coronaries: from plaques to genes to statins. Cell 161:1161–72
    [Google Scholar]
42. Gomes MD, Lecker SH, Jagoe RT, Navon A, Goldberg AL 2001. Atrogin-1, a muscle-specific F-box protein highly expressed during muscle atrophy. PNAS 98:2514440–45
    [Google Scholar]
43. Goodwin ML, Jin H, Straessler K, Smith-Fry K, Zhu J-F et al. 2014. Modeling alveolar soft part sarcomagenesis in the mouse: a role for lactate in the tumor microenvironment. Cancer Cell 26:6851–62
    [Google Scholar]
44. Guo JY, Chen H-Y, Mathew R, Fan J, Strohecker AM et al. 2011. Activated Ras requires autophagy to maintain oxidative metabolism and tumorigenesis. Genes Dev 25:5460–70
    [Google Scholar]
45. Guo JY, Teng X, Laddha SV, Ma S, Van Nostrand SC et al. 2016. Autophagy provides metabolic substrates to maintain energy charge and nucleotide pools in Ras-driven lung cancer cells. Genes Dev 30:151704–17
    [Google Scholar]
46. Haq R, Fisher DE 2011. Biology and clinical relevance of the micropthalmia family of transcription factors in human cancer. J. Clin. Oncol. 29:253474–82
    [Google Scholar]
47. Heckmann BL, Boada-Romero E, Cunha LD, Magne J, Green DR 2017. LC3-associated phagocytosis and inflammation. J. Mol. Biol. 429:233561–76
    [Google Scholar]
48. Hemesath TJ, Steingrímsson E, McGill G, Hansen MJ, Vaught J et al. 1994. Microphthalmia, a critical factor in melanocyte development, defines a discrete transcription factor family. Genes Dev 8:222770–80
    [Google Scholar]
49. Hershey CL, Fisher DE 2004. Mitf and Tfe3: members of a b-HLH-ZIP transcription factor family essential for osteoclast development and function. Bone 34:4689–96
    [Google Scholar]
50. Hodis E, Watson IR, Kryukov GV, Arold ST, Imielinski M et al. 2012. A landscape of driver mutations in melanoma. Cell 150:2251–63
    [Google Scholar]
51. Hoek KS, Eichhoff OM, Schlegel NC, Döbbeling U, Kobert N et al. 2008. In vivo switching of human melanoma cells between proliferative and invasive states. Cancer Res 68:3650–56
    [Google Scholar]
52. Huo Y, Cai H, Teplova I, Bowman-Colin C, Chen G et al. 2013. Autophagy opposes p53-mediated tumor barrier to facilitate tumorigenesis in a model of PALB2-associated hereditary breast cancer. Cancer Discov 3:8894–907
    [Google Scholar]
53. Ilagan E, Manning BD 2016. Emerging role of mTOR in the response to cancer therapeutics. Trends Cancer 2:5241–51
    [Google Scholar]
54. Jimenez AJ, Perez F 2017. Plasma membrane repair: the adaptable cell life-insurance. Curr. Opin. Cell Biol. 47:99–107
    [Google Scholar]
55. Kamphorst JJ, Cross JR, Fan J, de Stanchina E, Mathew R et al. 2013. Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. PNAS 110:228882–87
    [Google Scholar]
56. Kamphorst JJ, Nofal M, Commisso C, Hackett SR, Lu W et al. 2015. Human pancreatic cancer tumors are nutrient poor and tumor cells actively scavenge extracellular protein. Cancer Res 75:3544–53
    [Google Scholar]
57. Kaneko T, Zhang Z, Mantellini MG, Karl E, Zeitlin B et al. 2007. Bcl-2 orchestrates a cross-talk between endothelial and tumor cells that promotes tumor growth. Cancer Res 67:209685–93
    [Google Scholar]
58. Karsli-Uzunbas G, Guo JY, Price S, Teng X, Laddha SV et al. 2014. Autophagy is required for glucose homeostasis and lung tumor maintenance. Cancer Discov 4:8914–27
    [Google Scholar]
59. Kauffman EC, Ricketts CJ, Rais-Bahrami S, Yang Y, Merino MJ et al. 2014. Molecular genetics and cellular features of TFE3 and TFEB fusion kidney cancers. Nat. Rev. Urol. 11:8465–75
    [Google Scholar]
60. Kaur J, Debnath J 2015. Autophagy at the crossroads of catabolism and anabolism. Nat. Rev. Mol. Cell Biol. 16:8461–72
    [Google Scholar]
61. Kim E, Goraksha-Hicks P, Li L, Neufeld TP, Guan K-L 2008. Regulation of TORC1 by Rag GTPases in nutrient response. Nat. Cell Biol. 10:8935–45
    [Google Scholar]
62. Kitamura Y, Morii E, Jippo T, Ito A 2002. Regulation of mast cell phenotype by MITF. Int. Arch. Allergy Immunol. 127:2106–9
    [Google Scholar]
63. Kobos R, Nagai M, Tsuda M, Merl MY, Saito T et al. 2013. Combining integrated genomics and functional genomics to dissect the biology of a cancer-associated, aberrant transcription factor, the ASPSCR1-TFE3 fusion oncoprotein. J. Pathol. 229:5743–54
    [Google Scholar]
64. Konieczkowski DJ, Johannessen CM, Abudayyeh O, Kim JW, Cooper ZA et al. 2014. A melanoma cell state distinction influences sensitivity to MAPK pathway inhibitors. Cancer Discov 4:7816–27
    [Google Scholar]
65. Kuiper RP, Schepens M, Thijssen J, van Asseldonk M, van den Berg E et al. 2003. Upregulation of the transcription factor TFEB in t(6;11)(p21;q13)-positive renal cell carcinomas due to promoter substitution. Hum. Mol. Genet. 12:141661–69
    [Google Scholar]
66. Lazar AJF, Das P, Tuvin D, Korchin B, Zhu Q et al. 2007. Angiogenesis-promoting gene patterns in alveolar soft part sarcoma. Clin. Cancer Res. 13:247314–21
    [Google Scholar]
67. Leeman DS, Hebestreit K, Ruetz T, Webb AE, McKay A et al. 2018. Lysosome activation clears aggregates and enhances quiescent neural stem cell activation during aging. Science 359:63811277–83
    [Google Scholar]
68. Levine B, Deretic V 2007. Unveiling the roles of autophagy in innate and adaptive immunity. Nat. Rev. Immunol. 7:10767–77
    [Google Scholar]
69. Linehan WM, Ricketts CJ 2013. The metabolic basis of kidney cancer. Semin. Cancer Biol. 23:146–55
    [Google Scholar]
70. Linehan WM, Srinivasan R, Schmidt LS 2010. The genetic basis of kidney cancer: a metabolic disease. Nat. Rev. Urol. 7:5277–85
    [Google Scholar]
71. Lock R, Roy S, Kenific CM, Su JS, Salas E et al. 2011. Autophagy facilitates glycolysis during Ras-mediated oncogenic transformation. Mol. Biol. Cell. 22:2165–78
    [Google Scholar]
72. Lunt SY, Vander Heiden MG 2011. Aerobic glycolysis: meeting the metabolic requirements of cell proliferation. Annu. Rev. Cell Dev. Biol. 27:441–64
    [Google Scholar]
73. Lyssiotis CA, Kimmelman AC 2017. Metabolic interactions in the tumor microenvironment. Trends Cell Biol 27:11863–75
    [Google Scholar]
74. Mahalingam D, Mita M, Sarantopoulos J, Wood L, Amaravadi RK et al. 2014. Combined autophagy and HDAC inhibition: a phase I safety, tolerability, pharmacokinetic, and pharmacodynamic analysis of hydroxychloroquine in combination with the HDAC inhibitor vorinostat in patients with advanced solid tumors. Autophagy 10:81403–14
    [Google Scholar]
75. Maitra A, Hruban RH 2008. Pancreatic cancer. Annu. Rev. Pathol. 3:157–88
    [Google Scholar]
76. Mansueto G, Armani A, Viscomi C, D'Orsi L, De Cegli R et al. 2017. Transcription factor EB controls metabolic flexibility during exercise. Cell Metab 25:1182–96
    [Google Scholar]
77. Marchand B, Arsenault D, Raymond-Fleury A, Boisvert F-M, Boucher M-J 2015. Glycogen synthase kinase-3 (GSK3) inhibition induces prosurvival autophagic signals in human pancreatic cancer cells. J. Biol. Chem. 290:95592–605
    [Google Scholar]
78. Martina JA, Chen Y, Gucek M, Puertollano R 2012. MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB. Autophagy 8:6903–14
    [Google Scholar]
79. Martina JA, Diab HI, Lishu L, Jeong-A L, Patange S et al. 2014. The nutrient-responsive transcription factor TFE3 promotes autophagy, lysosomal biogenesis, and clearance of cellular debris. Sci. Signal. 7:309ra9
    [Google Scholar]
80. McAfee Q, Zhang Z, Samanta A, Levi SM, Ma X-H et al. 2012. Autophagy inhibitor Lys05 has single-agent antitumor activity and reproduces the phenotype of a genetic autophagy deficiency. PNAS 109:218253–58
    [Google Scholar]
81. McGill GG, Horstmann M, Widlund HR, Du J, Motyckova G et al. 2002. Bcl2 regulation by the melanocyte master regulator Mitf modulates lineage survival and melanoma cell viability. Cell 109:6707–18
    [Google Scholar]
82. Medina DL, Di Paola S, Peluso I, Armani A, De Stefani D et al. 2015. Lysosomal calcium signalling regulates autophagy through calcineurin and TFEB. Nat. Cell Biol. 17:3288–99
    [Google Scholar]
83. Medina DL, Fraldi A, Bouche V, Annunziata F, Mansueto G et al. 2011. Transcriptional activation of lysosomal exocytosis promotes cellular clearance. Dev. Cell. 21:3421–30
    [Google Scholar]
84. Miller AJ, Levy C, Davis IJ, Razin E, Fisher DE 2005. Sumoylation of MITF and its related family members TFE3 and TFEB. J. Biol. Chem. 280:1146–55
    [Google Scholar]
85. Mizushima N, Komatsu M 2011. Autophagy: renovation of cells and tissues. Cell 147:4728–41
    [Google Scholar]
86. Monkkonen T, Debnath J 2018. Inflammatory signaling cascades and autophagy in cancer. Autophagy 14:2190–98
    [Google Scholar]
87. Müller J, Krijgsman O, Tsoi J, Robert L, Hugo W et al. 2014. Low MITF/AXL ratio predicts early resistance to multiple targeted drugs in melanoma. Nat. Commun. 5:5712
    [Google Scholar]
88. Naegeli KM, Hastie E, Garde A, Wang Z, Keeley DP et al. 2017. Cell invasion in vivo via rapid exocytosis of a transient lysosome-derived membrane domain. Dev. Cell. 43:4403–17.e10
    [Google Scholar]
89. Napolitano G, Ballabio A 2016. TFEB at a glance. J. Cell Sci. 129:132475–81
    [Google Scholar]
90. Olson OC, Joyce JA 2015. Cysteine cathepsin proteases: regulators of cancer progression and therapeutic response. Nat. Rev. Cancer 15:12712–29
    [Google Scholar]
91. O'Rourke EJ, Ruvkun G 2013. MXL-3 and HLH-30 transcriptionally link lipolysis and autophagy to nutrient availability. Nat. Cell Biol. 15:6668–76
    [Google Scholar]
92. Palm W, Park Y, Wright K, Pavlova NN, Tuveson DA et al. 2015. The utilization of extracellular proteins as nutrients is suppressed by mTORC1. Cell 162:2259–70
    [Google Scholar]
93. Palmieri M, Impey S, Kang H, di Ronza A, Pelz C et al. 2011. Characterization of the CLEAR network reveals an integrated control of cellular clearance pathways. Hum. Mol. Genet. 20:193852–66
    [Google Scholar]
94. Peña-Llopis S, Vega-Rubín-de-Celis S, Liao A, Leng N, Pavía-Jiménez A et al. 2012. BAP1 loss defines a new class of renal cell carcinoma. Nat. Genet. 44:7751–59
    [Google Scholar]
95. Peña-Llopis S, Vega-Rubin-de-Celis S, Schwartz JC, Wolff NC, Tran TAT et al. 2011. Regulation of TFEB and V-ATPases by mTORC1. EMBO J 30:163242–58
    [Google Scholar]
96. Perera RM, Bardeesy N 2015. Pancreatic cancer metabolism: breaking it down to build it back up. Cancer Discov 5:121247–61
    [Google Scholar]
97. Perera RM, Stoykova S, Nicolay BN, Ross KN, Fitamant J et al. 2015. Transcriptional control of autophagy-lysosome function drives pancreatic cancer metabolism. Nature 524:7565361–65
    [Google Scholar]
98. Piao S, Amaravadi RK 2016. Targeting the lysosome in cancer. Ann. N.Y. Acad. Sci. 1371:145–54
    [Google Scholar]
99. Ploper D, Taelman VF, Robert L, Perez BS, Titz B et al. 2015. MITF drives endolysosomal biogenesis and potentiates Wnt signaling in melanoma cells. PNAS 112:5E420–29
    [Google Scholar]
100. Polishchuk EV, Concilli M, Iacobacci S, Chesi G, Pastore N et al. 2014. Wilson disease protein ATP7B utilizes lysosomal exocytosis to maintain copper homeostasis. Dev. Cell. 29:6686–700
     [Google Scholar]
101. Potente M, Gerhardt H, Carmeliet P 2011. Basic and therapeutic aspects of angiogenesis. Cell 146:6873–87
     [Google Scholar]
102. Qi X, Hong J, Chaves L, Zhuang Y, Chen Y et al. 2013. Antagonistic regulation by the transcription factors C/EBPα and MITF specifies basophil and mast cell fates. Immunity 39:197–110
     [Google Scholar]
103. Rabinowitz JD, White E 2010. Autophagy and metabolism. Science 330:60091344–48
     [Google Scholar]
104. Ramphal R, Pappo A, Zielenska M, Grant R, Ngan B-Y 2006. Pediatric renal cell carcinoma: clinical, pathologic, and molecular abnormalities associated with the members of the MiT transcription factor family. Am. J. Clin. Pathol. 126:3349–64
     [Google Scholar]
105. Rangwala R, Leone R, Chang YC, Fecher LA, Schuchter LM et al. 2014. Phase I trial of hydroxychloroquine with dose-intense temozolomide in patients with advanced solid tumors and melanoma. Autophagy 10:81369–79
     [Google Scholar]
106. Rao S, Tortola L, Perlot T, Wirnsberger G, Novatchkova M et al. 2014. A dual role for autophagy in a murine model of lung cancer. Nat. Commun. 5:3056
     [Google Scholar]
107. Rebecca VW, Nicastri MC, McLaughlin N, Fennelly C, McAfee Q et al. 2017. A unified approach to targeting the lysosome's degradative and growth signaling roles. Cancer Discov 7:111266–83
     [Google Scholar]
108. Reddy A, Caler EV, Andrews NW 2001. Plasma membrane repair is mediated by Ca²⁺-regulated exocytosis of lysosomes. Cell 106:2157–69
     [Google Scholar]
109. Roczniak-Ferguson A, Petit CS, Froehlich F, Qian S, Ky J et al. 2012. The transcription factor TFEB links mTORC1 signaling to transcriptional control of lysosome homeostasis. Sci. Signal. 5:228ra42
     [Google Scholar]
110. Rodrik-Outmezguine VS, Okaniwa M, Yao Z, Novotny CJ, McWhirter C et al. 2016. Overcoming mTOR resistance mutations with a new-generation mTOR inhibitor. Nature 534:7606272–76
     [Google Scholar]
111. Ryan DP, Hong TS, Bardeesy N 2014. Pancreatic adenocarcinoma. N. Engl. J. Med. 371:111039–49
     [Google Scholar]
112. Sancak Y, Bar-Peled L, Zoncu R, Markhard AL, Nada S, Sabatini DM 2010. Ragulator-Rag complex targets mTORC1 to the lysosomal surface and is necessary for its activation by amino acids. Cell 141:2290–303
     [Google Scholar]
113. Sancak Y, Peterson TR, Shaul YD, Lindquist RA, Thoreen CC et al. 2008. The Rag GTPases bind raptor and mediate amino acid signaling to mTORC1. Science 320:58821496–501
     [Google Scholar]
114. Sánchez-Gastaldo A, Kempf E, González Del Alba A, Duran I 2017. Systemic treatment of renal cell cancer: a comprehensive review. Cancer Treat. Rev. 60:77–89
     [Google Scholar]
115. Sandri M. 2016. Protein breakdown in cancer cachexia. Semin. Cell Dev. Biol. 54:11–19
     [Google Scholar]
116. Santanam U, Banach-Petrosky W, Abate-Shen C, Shen MM, White E, DiPaola RS 2016. Atg7 cooperates with Pten loss to drive prostate cancer tumor growth. Genes Dev 30:4399–407
     [Google Scholar]
117. Sardiello M, Palmieri M, di Ronza A, Medina DL, Valenza M et al. 2009. A gene network regulating lysosomal biogenesis and function. Science 325:5939473–77
     [Google Scholar]
118. Sato S, Roberts K, Gambino G, Cook A, Kouzarides T, Goding CR 1997. CBP/p300 as a co-factor for the Microphthalmia transcription factor. Oncogene 14:253083–92
     [Google Scholar]
119. Saxton RA, Sabatini DM 2017. mTOR signaling in growth, metabolism, and disease. Cell 169:2361–71
     [Google Scholar]
120. Schmidt L, Duh FM, Chen F, Kishida T, Glenn G et al. 1997. Germline and somatic mutations in the tyrosine kinase domain of the MET proto-oncogene in papillary renal carcinomas. Nat. Genet. 16:168–73
     [Google Scholar]
121. Schürmann A, Brauers A, Massmann S, Becker W, Joost HG 1995. Cloning of a novel family of mammalian GTP-binding proteins (RagA, RagBs, RagB1) with remote similarity to the Ras-related GTPases. J. Biol. Chem. 270:4828982–88
     [Google Scholar]
122. Sekiguchi T, Hirose E, Nakashima N, Ii M, Nishimoto T 2001. Novel G proteins, Rag C and Rag D, interact with GTP-binding proteins, Rag A and Rag B. J. Biol. Chem. 276:107246–57
     [Google Scholar]
123. Settembre C, Ballabio A 2014. Lysosome: regulator of lipid degradation pathways. Trends Cell Biol 24:12743–50
     [Google Scholar]
124. Settembre C, De Cegli R, Mansueto G, Saha PK, Vetrini F et al. 2013.a TFEB controls cellular lipid metabolism through a starvation-induced autoregulatory loop. Nat. Cell Biol. 15:6647–58
     [Google Scholar]
125. Settembre C, Di Malta C, Polito VA, Garcia Arencibia M, Vetrini F et al. 2011. TFEB links autophagy to lysosomal biogenesis. Science 332:60361429–33
     [Google Scholar]
126. Settembre C, Fraldi A, Medina DL, Ballabio A 2013.b Signals from the lysosome: a control centre for cellular clearance and energy metabolism. Nat. Rev. Mol. Cell Biol. 14:5283–96
     [Google Scholar]
127. Settembre C, Zoncu R, Medina DL, Vetrini F, Erdin S et al. 2012. A lysosome-to-nucleus signalling mechanism senses and regulates the lysosome via mTOR and TFEB: self-regulation of the lysosome via mTOR and TFEB. EMBO J 31:51095–108
     [Google Scholar]
128. Shibahara S, Yasumoto K, Amae S, Udono T, Watanabe K et al. 2000. Regulation of pigment cell-specific gene expression by MITF. Pigment Cell Res 13:Suppl. 898–102
     [Google Scholar]
129. Shipley JM, Birdsall S, Clark J, Crew J, Gill S et al. 1995. Mapping the X chromosome breakpoint in two papillary renal cell carcinoma cell lines with a t(X;1)(p11.2;q21.2) and the first report of a female case. Cytogenet. Cell Genet. 71:3280–84
     [Google Scholar]
130. Sidhar SK, Clark J, Gill S, Hamoudi R, Crew AJ et al. 1996. The t(X;1)(p11.2;q21.2) translocation in papillary renal cell carcinoma fuses a novel gene PRCC to the TFE3 transcription factor gene. Hum. Mol. Genet. 5:91333–38
     [Google Scholar]
131. Stacchiotti S, Tamborini E, Marrari A, Brich S, Rota SA et al. 2009. Response to sunitinib malate in advanced alveolar soft part sarcoma. Clin. Cancer Res. 15:31096–1104
     [Google Scholar]
132. Steingrímsson E, Copeland NG, Jenkins NA 2004. Melanocytes and the microphthalmia transcription factor network. Annu. Rev. Genet. 38:365–411
     [Google Scholar]
133. Steingrímsson E, Moore KJ, Lamoreux ML, Ferré-D'Amaré AR, Burley SK et al. 1994. Molecular basis of mouse microphthalmia (mi) mutations helps explain their developmental and phenotypic consequences. Nat. Genet. 8:3256–63
     [Google Scholar]
134. Steingrímsson E, Tessarollo L, Pathak B, Hou L, Arnheiter H et al. 2002. Mitf and Tfe3, two members of the Mitf-Tfe family of bHLH-Zip transcription factors, have important but functionally redundant roles in osteoclast development. PNAS 99:74477–82
     [Google Scholar]
135. Steingrímsson E, Tessarollo L, Reid SW, Jenkins NA, Copeland NG 1998. The bHLH-Zip transcription factor Tfeb is essential for placental vascularization. Development 125:234607–16
     [Google Scholar]
136. Strohecker AM, Guo JY, Karsli-Uzunbas G, Price SM, Chen GJ et al. 2013. Autophagy sustains mitochondrial glutamine metabolism and growth of Braf^V600E-driven lung tumors. Cancer Discov 3:111272–85
     [Google Scholar]
137. Subramani S, Malhotra V 2013. Non-autophagic roles of autophagy-related proteins. EMBO Rep 14:2143–51
     [Google Scholar]
138. Tachibana M, Takeda K, Nobukuni Y, Urabe K, Long JE et al. 1996. Ectopic expression of MITF, a gene for Waardenburg syndrome type 2, converts fibroblasts to cells with melanocyte characteristics. Nat. Genet. 14:150–54
     [Google Scholar]
139. Tanaka M, Homme M, Yamazaki Y, Shimizu R, Takazawa Y, Nakamura T 2017. Modeling alveolar soft part sarcoma unveils novel mechanisms of metastasis. Cancer Res 77:4897–907
     [Google Scholar]
140. Tanaka M, Kato K, Gomi K, Matsumoto M, Kudo H et al. 2009. Perivascular epithelioid cell tumor with SFPQ/PSF-TFE3 gene fusion in a patient with advanced neuroblastoma. Am. J. Surg. Pathol. 33:91416–20
     [Google Scholar]
141. Tirosh I, Izar B, Prakadan SM, Wadsworth MH, Treacy D et al. 2016. Dissecting the multicellular ecosystem of metastatic melanoma by single-cell RNA-seq. Science 352:6282189–96
     [Google Scholar]
142. Trisciuoglio D, Gabellini C, Desideri M, Ragazzoni Y, De Luca T et al. 2011. Involvement of BH4 domain of bcl-2 in the regulation of HIF-1-mediated VEGF expression in hypoxic tumor cells. Cell Death Differ 18:61024–35
     [Google Scholar]
143. Tsao H, Chin L, Garraway LA, Fisher DE 2012. Melanoma: from mutations to medicine. Genes Dev 26:111131–55
     [Google Scholar]
144. Vogl DT, Stadtmauer EA, Tan K-S, Heitjan DF, Davis LE et al. 2014. Combined autophagy and proteasome inhibition: a phase 1 trial of hydroxychloroquine and bortezomib in patients with relapsed/refractory myeloma. Autophagy 10:81380–90
     [Google Scholar]
145. Wei H, Wei S, Gan B, Peng X, Zou W, Guan J-L 2011. Suppression of autophagy by FIP200 deletion inhibits mammary tumorigenesis. Genes Dev 25:141510–27
     [Google Scholar]
146. Weterman MA, Wilbrink M, Geurts van Kessel A 1996. Fusion of the transcription factor TFE3 gene to a novel gene, PRCC, in t(X;1)(p11;q21)-positive papillary renal cell carcinomas. PNAS 93:2615294–98
     [Google Scholar]
147. Weterman MJ, van Groningen JJ, Jansen A, van Kessel AG 2000. Nuclear localization and transactivating capacities of the papillary renal cell carcinoma-associated TFE3 and PRCC (fusion) proteins. Oncogene 19:169–74
     [Google Scholar]
148. White E. 2015. The role for autophagy in cancer. J. Clin. Investig. 125:142–46
     [Google Scholar]
149. Xie X, Koh JY, Price S, White E, Mehnert JM 2015. Atg7 overcomes senescence and promotes growth of Braf^V600E-driven melanoma. Cancer Discov 5:4410–23
     [Google Scholar]
150. Xu Q, Krause M, Samoylenko A, Vainio S 2016. Wnt signaling in renal cell carcinoma. Cancers 8:657
     [Google Scholar]
151. Yang A, Herter-Sprie G, Zhang H, Lin EY, Biancur D et al. 2018. Autophagy sustains pancreatic cancer growth through both cell-autonomous and nonautonomous mechanisms. Cancer Discov 8:3276–87
     [Google Scholar]
152. Yang A, Rajeshkumar NV, Wang X, Yabuuchi S, Alexander BM et al. 2014. Autophagy is critical for pancreatic tumor growth and progression in tumors with p53 alterations. Cancer Discov 4:8905–13
     [Google Scholar]
153. Yang R, Zheng Y, Li L, Liu S, Burrows M et al. 2014. Direct conversion of mouse and human fibroblasts to functional melanocytes by defined factors. Nat. Commun. 5:5807
     [Google Scholar]
154. Yang S, Wang X, Contino G, Liesa M, Sahin E et al. 2011. Pancreatic cancers require autophagy for tumor growth. Genes Dev 25:7717–29
     [Google Scholar]
155. Yecies JL, Manning BD 2011. mTOR links oncogenic signaling to tumor cell metabolism. J. Mol. Med. 89:3221–28
     [Google Scholar]
156. Ying H, Dey P, Yao W, Kimmelman AC, Draetta GF et al. 2016. Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev 30:4355–85
     [Google Scholar]
157. Yokoyama S, Woods SL, Boyle GM, Aoude LG, MacGregor S et al. 2011. A novel recurrent mutation in MITF predisposes to familial and sporadic melanoma. Nature 480:737599–103
     [Google Scholar]
158. Zhou Y, Tang F, Wang Y, Min L, Luo Y et al. 2017. Advanced alveolar soft part sarcoma responds to apatinib. Oncotarget 8:3050314–22
     [Google Scholar]
159. Zoncu R, Bar-Peled L, Efeyan A, Wang S, Sancak Y, Sabatini DM 2011. mTORC1 senses lysosomal amino acids through an inside-out mechanism that requires the vacuolar H⁺-ATPase. Science 334:6056678–83
     [Google Scholar]